Success Story: NIW Approved With No RFE Issued for a Ghanaian PhD Candidate Through Our Expert Strategy
Client’s Testimonial:
“As a Ghanaian PhD candidate with a strong research background but limited policy knowledge, I was initially overwhelmed by the NIW process. The team provided a clear strategy tailored to my scientific achievements and long-term goals. Thanks to their expert guidance, my petition was approved without an RFE. I’m incredibly grateful for their support and highly recommend their services to any researcher navigating the NIW process.”
On April 11th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: PhD Candidate
Country of Origin: Ghana
State of Residence at the Time of Filing: New York
Approval Notice Date: April 11th, 2025
Processing Time: 1 year, 4 months
Case Summary:
We’re thrilled to share the successful approval of a National Interest Waiver (NIW) I-140 petition for an MS holder in biomedical engineering. Approved after 16 months, this case highlights the power of strong scientific evidence, expert support, and clearly defined national relevance.
Advancing Therapies for Musculoskeletal Disease, Cancer, and Immune Disorders
The petitioner’s research focuses on innovative pharmacological solutions using engineered peptide-functionalized nanoparticles. Her work enhances tendon regeneration, improves bone health, and addresses drug resistance in cancer. By combining nanotech, biomedical devices, and drug delivery, she is contributing cutting-edge tools to tackle critical health challenges.
She currently works at a U.S. academic institution, continuing to develop therapies that serve both scientific advancement and public health needs.
Recognized Scientific Impact
Her record includes:
● 6 peer-reviewed articles (3 first-authored), 1 preprint, and 1 patent application;
● 30 citations from global researchers;
● Research funding support from both the National Institutes of Health (NIH) and the National Science Foundation (NSF);
Backed by Independent Experts4 recommendation letters from top researchers in neurology, orthopedics, dentistry, and biomedical science confirmed her contributions:
“Her remarkable contributions to the field of biomedical engineering have substantially contributed to the development of innovative approaches for promoting bone and tendon regeneration. [Client] has made significant strides in the areas of nanoparticle drug delivery, musculoskeletal tissue regeneration, and cancer and immunology research, leaving an indelible mark on the field.”
Serving U.S. National InterestsHer research addresses U.S. priorities in biotechnology and advanced materials, tackling costly, chronic health burdens. With NIW approval, she is poised to continue making transformative contributions in biomedical science. We are proud to have represented this exceptional scientist and look forward to seeing her contributions shape the next generation of pharmaceutical research and clinical outcomes.